Creo Medical Limited

$11.50+1.10%(+$0.13)
TickerSpark Score
56/100
Mixed
84
Valuation
90
Profitability
10
Growth
68
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CREO.L research report →

52-Week Range22% of range
Low $9.52
Current $11.50
High $18.50

Companycreomedical.com

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues.

CEO
Craig Jonathan Gulliford
IPO
2016
Employees
278
HQ
Chepstow, GB

Price Chart

-8.00% · this period
$17.75$13.82$9.90May 23Nov 19May 21

Valuation

Market Cap
$47.43M
P/E
2.88
P/S
21.56
P/B
0.80
EV/EBITDA
-3.28
Div Yield
0.00%

Profitability

Gross Margin
45.45%
Op Margin
-454.55%
Net Margin
768.18%
ROE
32.72%
ROIC
-14.60%

Growth & Income

Revenue
$4.00M · -87.01%
Net Income
$-28,700,000 · -32.26%
EPS
$-0.08 · -14.57%
Op Income
$-28,800,000
FCF YoY
0.88%

Performance & Tape

52W High
$18.50
52W Low
$9.52
50D MA
$12.13
200D MA
$12.25
Beta
1.62
Avg Volume
585.24K

Get TickerSpark's AI analysis on CREO.L

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our CREO.L Coverage

We haven't published any research on CREO.L yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate CREO.L Report →

Similar Companies